日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca(2+) dependent allosteric binding site.

通过靶向 Ca(2+) 依赖性变构结合位点来抑制肽基精氨酸脱亚胺酶 (PAD1-4)

Dakin Leslie A, Xing Li, Hall Justin, Ding Weidong, Vajdos Felix F, Pelker Jeffrey W, Ramsey Simeon, Balbo Paul, Sahasrabudhe Parag V, Banker Mary Ellen, Choi Won Young, Wright Stephen W, Chang Jeanne S, Curto John M, Davoren Jennifer E, Drozda Susan E, Fennell Kimberly F, Futatsugi Kentaro, Kortum Steve, Lee Katherine L, Liu Shenping, Lovering Frank, Nicki Jennifer A, Trujillo John I, Vincent Fabien, Schnute Mark E

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine.

Omicron XBB.1.5 适应性 BNT162b2 COVID-19 疫苗的临床前表征

Modjarrad Kayvon, Che Ye, Chen Wei, Wu Huixian, Cadima Carla I, Muik Alexander, Maddur Mohan S, Tompkins Kristin R, Martinez Lyndsey T, Cai Hui, Ramos Minah, Mensah Sonia, Cumbia Brittney, Falcao Larissa, McKeen Andrew P, Chang Jeanne S, Fennell Kimberly F, Huynh Kevin W, McLellan Thomas J, Sahasrabudhe Parag V, Chen Wei, Cerswell Michael, Garcia Miguel A, Li Shilong, Sharma Rahul, Li Weiqiang, Dizon Kristianne P, Duarte Stacy, Gillett Frank, Smith Rachel, Illenberger Deanne M, Efferen Kari Sweeney, Vogel Annette B, Anderson Annaliesa S, Şahin Uğur, Swanson Kena A